DRTS — Alpha Tau Medical Balance Sheet
0.000.00%
Last trade - 00:00
- $173.48m
- $97.30m
- 42
- 27
- 41
- 29
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | 20-F | 20-F |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 28.1 | 46 | 31.3 | 105 | 81.8 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.564 | 0.005 | 0.022 | 0.032 | 0.019 |
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 29.8 | 47.5 | 32.6 | 106 | 85.8 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 1.71 | 5.39 | 7.55 | 13.3 | 21.2 |
Other Long Term Assets | |||||
Total Assets | 31.6 | 53 | 42.2 | 120 | 107 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 1.35 | 2.09 | 4.41 | 4.34 | 7.1 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 6.51 | 7.45 | 23 | 14.5 | 22.9 |
Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 25 | 45.5 | 19.2 | 106 | 84.5 |
Total Liabilities & Shareholders' Equity | 31.6 | 53 | 42.2 | 120 | 107 |
Total Common Shares Outstanding |